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SUMMARY. The use of mercaptoacetyltriglycine (MAG3) as a radiopharmaceutical is well known. The
MAG3 is formerly called Technetium-99m (99mTc) mercaptoacetyltriglycine and it is the standard radio-
pharmaceuticals for renal scintilography . In this study we propose three methodologies based on the use
of a new stationary phase (paper Hahnemuhle) and a mobile phase. The results showed that all the three
conditions were very close, and for this reason can be interchangeable.
